Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06510166

The Effect of Distraction Methods Used During Inhalation Therapy on Children's Fear and Anxiety: : Randomize Controlled Study

Conditions: Child, Inhalation Therapy; Complications, Fear, Distraction Methods, Anxiety

Sex: All
Ages: 3 Years – 6 Years
Healthy volunteers: No
Phase: NA
Enrollment: 120
Sponsor: Ondokuz Mayıs University

Location: Ondokuz Mayıs University Samsun Atakum

Summary

It was aimed to examine the effects of distraction methods used during inhalation therapy on children's fear and anxiety. Hypothesis: Hypothesis 0 (H0): There is no difference between the fear and anxiety levels of children who received normal nebulizer + mask + distraction techniques and toy type nebulizer + toy mask during inhaler treatment and the children in the control group. Hypothesis 1 (H1): The fear and anxiety levels of children who received normal nebulizer + mask + distraction techniques during inhaler treatment are lower than the children in the control group. Hypothesis 2 (H2): The fear and anxiety levels of children who were applied a toy type nebulizer + toy mask during inhaler treatment are lower than the children in the control group. Hypothesis 3 (H3): The fear and anxiety levels of children who were treated with a toy type nebulizer + toy mask during inhaler treatment were lower than those of children who were treated with a normal nebulizer + mask + distraction techniques.

Eligibility Criteria

Inclusion Criteria: * Parent and child volunteer to participate in the study, * The child is between 3-6 years old, * Presentation due to upper and lower respiratory tract infection, * Inhaler treatment will be applied with a nebulizer, * No request for any other intravenous, intramuscular or invasive treatment, * The child does not have any genetic, congenital, chronic or metabolic disease, Exclusion Criteria: * Parent and child are not willing to participate in the study, * The child is not between 3-6 years old, * Presentation for a reason other than upper and lower respiratory tract infection, * No inhaler treatment with a nebulizer, * Request for any other intravenous, intramuscular or invasive treatment, * The child has any genetic, congenital, chronic or metabolic disease

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06510166). StuddyBuddy aggregates publicly available trial information.